What Happened?
Germantown, MD-based Precigen Resigned Rick Sterling as Chief Financial Officer
About the Company
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
About the Person
Rick Sterling is Chief Financial Officer at Precigen. Previously, Rick held various senior HR leadership roles in the industry.
Info Source
News
Short Profile